1 (Nelarabine Injection 1)
Nelarabine Injection
Product Images NDC 70121-1743
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 70121-1743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Nelarabine Injection 2)
1 (Nelarabine Injection 3)
This is a description of a medication called "Nelarabine Injection" that comes in 6 single-dose vials of 50 mL. Each vial contains 250 mg/50mL (5mg/mL) of the medication. It is a cytotoxic agent used for intravenous infusion only and should be discarded if any unused portion remains. The injection must not be diluted and contains no preservatives. The package insert should be consulted for usual dosages. The medication contains Nelrabine (5mg), Sodium chloride (45mg), and Water for injection. It should be stored within a temperature range of 20°C to 25°C (68°F to 77°F) with permissible excursions of 15°C to 30°C (59°F to 86°F). The vial stoppers are made without natural rubber latex. The medication is manufactured by Amneal Oncology Pt. Ltd. in Telangana, India, and distributed by Amneal Pharmaceuticals LLC in Bridgewater, N.J.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
